Catalyst

Slingshot members are tracking this event:

Topline results of PRX002 from Phase 1b multiple ascending dose study in patients with Parkinson's disease expected in the fourth quarter of 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PRTA Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 09, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Prx002, Phase 1b, Parkinson's Disease, Q4 2016